Table 3.
Neuropsychological tests values at baseline
| Test | Placebo a | Interferon beta 1a a | P value |
|---|---|---|---|
| ADAS-Cogb |
19.81 ± 6.14 |
18.34 ± 7.85 |
0.34 |
| MMSEc |
22.93 ± 1.78 |
23.45 ± 2.13 |
0.41 |
| ADAS-NonCogd |
6.06 ± 5.0 |
4.36 ± 4.12 |
0.30 |
| PSMSe |
6.4 ± 0.91 |
6.42 ± 1.01 |
0.98 |
| GDSf |
10.66 ± 6.53 |
10.10 ± 6.12 |
0.79 |
| Global DSg |
2.86 ± 0.74 |
3.0 ± 0.47 |
0.50 |
| IADLh | 6.2 ± 1.56 | 6.1 ± 1.44 | 0.68 |
aValues are expressed as means ± SD. bADAS-cog, Alzheimer’s Disease Assessment Scale-cognitive subscale; cMMSE, Mini Mental State Examination; dADAS-Non-Cog, Alzheimer’s Disease Assessment Scale-Non-Cognitive Section; ePSMS, Physical Self-Maintenance Scale; fGDS, Geriatric Depression Scale; Global, gGlobal Deterioration Scale (DS) for Assessment of Primary Degenerative Dementia; hIADL, Instrumental Activities of Daily Living Scale.